Stock Report

Blue Jet Healthcare Reports Q1 FY27 Results: Net Profit Reaches ₹78.26 Crore; Revenue Up 24.9% QoQ

Posted On : 2026-08-03 21:41:59( TIMEZONE : IST )

Pharmaceutical and healthcare intermediate manufacturer Blue Jet Healthcare Limited announced its unaudited financial results for the first quarter ended June 30, 2026 (Q1 FY27).

The company reported a consolidated net profit of ₹78.26 crore (₹782.64 million) for the quarter, reflecting a sharp 21.6% quarter-on-quarter (QoQ) recovery driven by sequentially higher operational revenues, though performance saw a 14.2% year-on-year (YoY) contraction against a high base in Q1 FY26.

Financial Performance Summary
(Figures in ₹ Crore, converted from ₹ Millions)

Revenue from Operations: Stood at ₹293.11 crore in Q1 FY27, registering a robust 24.9% QoQ expansion compared to ₹234.67 crore in Q4 FY26. On a YoY basis, revenue declined 17.4% from ₹354.76 crore in Q1 FY26.

Total Income: Reached ₹308.35 crore, including other income of ₹15.24 crore, up 19.7% QoQ from ₹257.59 crore in Q4 FY26.

Profit Before Tax (PBT): Expanded to ₹105.95 crore in Q1 FY27, posting a 21.6% QoQ increase over ₹87.15 crore in Q4 FY26. PBT declined 13.8% YoY compared to ₹122.86 crore in Q1 FY26.

Profit After Tax (PAT): Stood at ₹78.26 crore (PAT margin of 26.7%), up 21.6% QoQ from ₹64.34 crore in Q4 FY26, and down 14.2% YoY from ₹91.17 crore in Q1 FY26.

Total Comprehensive Income: Came in at ₹78.26 crore for the quarter, compared to ₹64.44 crore in Q4 FY26 and ₹91.17 crore in Q1 FY26.

Operating Expenditure Breakdown

Total expenses for Q1 FY27 stood at ₹202.40 crore, compared to ₹170.44 crore in Q4 FY26 and ₹240.15 crore in Q1 FY26:

Cost of Materials Consumed: Stood at ₹178.88 crore, up from ₹92.89 crore in Q4 FY26 and ₹107.89 crore in Q1 FY26.

Changes in Inventories: Recorded a credit of ₹(41.77) crore, reflecting inventory buildup during the quarter, compared to ₹9.32 crore in Q4 FY26 and ₹75.01 crore in Q1 FY26.

Employee Benefits Expense: Stood at ₹20.12 crore, compared to ₹18.48 crore in Q4 FY26 and ₹17.43 crore in Q1 FY26.

Finance Costs: Remained nominal at ₹0.66 crore, compared to ₹0.58 crore in Q4 FY26 and ₹0.69 crore in Q1 FY26.

Depreciation & Amortization: Totaled ₹6.71 crore, compared to ₹6.46 crore in Q4 FY26 and ₹5.70 crore in Q1 FY26.

Other Expenses: Stood at ₹37.81 crore, down 11.5% QoQ from ₹42.72 crore in Q4 FY26.

Share Capital & Earnings Per Share

Paid-Up Equity Share Capital: Stood at ₹34.69 crore (₹346.93 million) with a face value of ₹2 per share.

Other Equity: Total other equity as of March 31, 2026, was recorded at ₹1,325.22 crore.

Earnings Per Share (EPS): Basic and diluted EPS for the quarter reached ₹4.51 per share (not annualised), compared to ₹3.71 in Q4 FY26 and ₹5.26 in Q1 FY26.

Shares of Blue Jet Healthcare Limited was last trading in BSE at Rs. 589.40 as compared to the previous close of Rs. 627.05. The total number of shares traded during the day was 313390 in over 7305 trades.

The stock hit an intraday high of Rs. 647.05 and intraday low of 578.00. The net turnover during the day was Rs. 190409711.00.